Jaffetilchin Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43M Buy
4,078
+74
+2% +$26.4K 0.09% 154
2025
Q4
$1.31M Buy
4,004
+4
+0.1% +$1.27K 0.08% 162
2025
Q3
$1.13M Sell
4,000
-95
-2% -$27.6K 0.07% 178
2025
Q2
$1.14M Sell
4,095
-1,262
-24% -$358K 0.07% 164
2025
Q1
$1.67M Buy
5,357
+1,397
+35% +$413K 0.12% 125
2024
Q4
$1.03M Buy
3,960
+1,775
+81% +$527K 0.07% 160
2024
Q3
$704K Buy
2,185
+309
+16% +$101K 0.05% 187
2024
Q2
$586K Buy
1,876
+42
+2% +$12.3K 0.05% 195
2024
Q1
$521K Sell
1,834
-2,145
-54% -$628K 0.05% 203
2023
Q4
$1.15M Buy
3,979
+182
+5% +$49.6K 0.11% 120
2023
Q3
$1.02M Buy
3,797
+2,085
+122% +$520K 0.11% 115
2023
Q2
$380K Sell
1,712
-268
-14% -$62.2K 0.04% 239
2023
Q1
$479K Buy
1,980
+1,101
+125% +$270K 0.05% 208
2022
Q4
$231K Buy
+879
New +$236K 0.03% 317
2022
Q3
Sell
-3,724
Closed -$906K 315
2022
Q2
$906K Buy
3,724
+52
+1% +$12.7K 0.11% 129
2022
Q1
$898K Buy
3,672
+1,736
+90% +$399K 0.11% 127
2021
Q4
$436K Buy
1,936
+564
+41% +$119K 0.04% 231
2021
Q3
$292K Buy
1,372
+112
+9% +$25.8K 0.03% 279
2021
Q2
$307K Sell
1,260
-991
-44% -$244K 0.02% 322
2021
Q1
$560K Sell
2,251
-370
-14% -$88.3K 0.07% 187
2020
Q4
$603K Buy
2,621
+76
+3% +$17.5K 0.09% 147
2020
Q3
$647K Buy
2,545
+230
+10% +$57K 0.12% 102
2020
Q2
$546K Buy
+2,315
New +$528K 0.12% 105
2018
Q4
Sell
-1,586
Closed -$329K 259
2018
Q3
$329K Buy
1,586
+60
+4% +$11.8K 0.07% 217
2018
Q2
$282K Buy
+1,526
New +$270K 0.06% 233
2017
Q4
Sell
-3,621
Closed -$675K 229
2017
Q3
$675K Buy
+3,621
New +$642K 0.16% 113
2017
Q2
Sell
-3,909
Closed -$641K 222
2017
Q1
$641K Buy
3,909
+508
+15% +$84.4K 0.16% 102
2016
Q4
$497K Buy
3,401
+946
+39% +$142K 0.15% 118
2016
Q3
$410K Buy
2,455
+896
+57% +$152K 0.13% 125
2016
Q2
$237K Sell
1,559
-1,145
-42% -$178K 0.07% 192
2016
Q1
$405K Buy
+2,704
New +$402K 0.13% 104
2015
Q4
Sell
-2,350
Closed -$325K 186
2015
Q3
$325K Buy
2,350
+4
+0.2% +$631 0.12% 131
2015
Q2
$360K Buy
2,346
+11
+0.5% +$1.76K 0.11% 144
2015
Q1
$373K Sell
2,335
-2,720
-54% -$428K 0.11% 141
2014
Q4
$805K Buy
5,055
+2,443
+94% +$381K 0.27% 61
2014
Q3
$367K Buy
2,612
+3
+0.1% +$392 0.13% 129
2014
Q2
$309K Buy
2,609
+4
+0.2% +$463 0.11% 168
2014
Q1
$321K Buy
2,605
+3
+0.1% +$364 0.13% 144
2013
Q4
$297K Buy
2,602
+38
+1% +$4.32K 0.15% 148
2013
Q3
$287K Hold
2,564
0.17% 131
2013
Q2
$253K Buy
+2,564
New +$266K 0.18% 152

Other funds holding AMGN

Jaffetilchin Investment Partners's AMGN Position: Q1 2026 in Review

Jaffetilchin Investment Partners increased its Amgen (AMGN) stake by 1.8% in Q1 2026, buying an estimated $26.4K and bringing the position to 4,078 shares worth $1.43M. The position accounts for 0.09% of the portfolio, ranked #154.

Jaffetilchin Investment Partners first reported a position in AMGN in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.67M in Q1 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Jaffetilchin Investment Partners held 4,078 shares of Amgen worth $1.43M as of Q1 2026.
  • Jaffetilchin Investment Partners bought 74 Amgen shares in Q1 2026, an estimated $26.4K.
  • Amgen made up 0.09% of Jaffetilchin Investment Partners's portfolio in Q1 2026, its #154 holding.
  • Jaffetilchin Investment Partners first reported a position in Amgen in Q2 2013 and has held it in 41 quarters since.
  • Jaffetilchin Investment Partners's Amgen position peaked at $1.67M in Q1 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Jaffetilchin Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.